Skip to main content
  • More from ADA
    • Diabetes
    • Diabetes Care
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Clinical Diabetes

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
  • Browse
    • Issue Archive
    • Saved Searches
    • COVID-19 Article Collection
    • Quality Improvement Sucess Stories
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
  • Advertising
  • Reprints/Reuse
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • Instructions for Authors
    • ADA Journal Policies
  • More from ADA
    • Diabetes
    • Diabetes Care
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Clinical Diabetes
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
  • Browse
    • Issue Archive
    • Saved Searches
    • COVID-19 Article Collection
    • Quality Improvement Sucess Stories
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
  • Advertising
  • Reprints/Reuse
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • Instructions for Authors
    • ADA Journal Policies
Feature Articles

Inpatient and Outpatient Technologies to Assist in the Management of Insulin Dosing

  1. Ling Cui,
  2. Pamela R. Schroeder and
  3. Paul A. Sack
  1. Department of Medicine, MedStar Union Memorial Hospital, Baltimore, MD
  1. Corresponding author: Paul A. Sack, paul.a.sack{at}medstar.net
Clinical Diabetes 2020 Dec; 38(5): 462-473. https://doi.org/10.2337/cd20-0054
PreviousNext
  • Article
  • Figures & Tables
  • Info & Metrics
  • PDF
Loading

Article Figures & Tables

Figures

  • Tables
  • FIGURE 1
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1

    Array of slopes representing the multipliers. In this example, the initial blood glucose level (295 mg/dL) is plotted on the 0.02 slope, indicating the initial insulin rate (4.7 units/hour). The second blood glucose level has decreased from 295 to 256 mg/dL. Therefore, the multiplier is increased by 25%, increasing the insulin dose to 4.9 units/hour. Subsequent serially measured blood glucose levels decrease satisfactorily (205 mg/dL followed by 3.6 units/hour, 168 mg/dL followed by 2.7 units/hour, and 115 mg/dL followed by 1.5 units/hour) until the blood glucose level is less than the low target value (69 mg/dL followed by 0.2 units/hour). At that time, the multiplier shifted downward, and the next two blood glucose levels and insulin doses (98 mg/dL followed by 0.8 units/hour and 110 mg/dL followed by 1 unit/hour) centered in the target range. Reprinted with permission from ref. 19.

Tables

  • Figures
  • TABLE 1

    Comparison of Inpatient Electronic Glucose Management Systems

    ProductRecommends IV Insulin Doses?Supports IV-to-SQ Transitions?Recommends SQ Insulin Doses?Available Software Additions for Data ManagementAdditional Notes
    GlucommanderYesYesYesGlucoMetrics, GlucoSurveillance, GlucoView, GlyCloud, SmartClickAlso approved for outpatient SQ insulin management
    EndoToolYesYesYesEndoTool AnalyticsSupports parenteral carbohydrate calculation
    GlucoStabilizerYesYesDevelopingGlucoStabilizer Reports: inbound admit, transfer, discharge; outbound patient information integration in EMR; carbohydrate coverage for patients who are eating
    Core Diabetes AppYesYesYesCore Work Manager App, Core Notify App, Core Messaging AppDoes not adjust the insulin dose automatically
  • TABLE 2

    Comparison of Outpatient Electronic Glycemic Management Systems

    ProductSupports Long-Acting Insulin Dosing?Supports Rapid-Acting Insulin Dosing?FormatFor Use With Which Type(s) of Diabetes?Information InputOther Functions
    InsuliaYesNoMobile app with Web-based portalType 2 diabetesManually enteredShares reports with providers; patients receive educational coaching messages; safety rules for hypoglycemia management
    iSage RxYesNoMobile app with Web-based portalType 2 diabetesManually enteredShares reports with providers
    Glooko’s Mobile Insulin Dosing SystemYesNoMobile app with Web-based platformType 2 diabetesMajority of meters use the Glooko MeterSync Blue device to transmit; data transits automatically from Dexcom CGM; no manual entry†Shares reports with providers
    My Dose CoachYesNoMobile app with Web-based portalType 2 diabetesManually enteredShares reports with providers
    InPenNoYes (Humalog, Novolog, Fiasp)Pen connected with app by BluetoothType 1 and type 2 diabetesManually entered; transmitted automatically from some Bluetooth-enabled blood glucose meters through Apple iHealth*; transmitted automatically from Dexcom CGMShares reports with providers; sends reminders to check blood glucose, inject insulin, and change cartilage after 28 days; displays last dose and current IOB; monitors insulin temperature
    Accu-Chek Bolus AdvisorNoYesMobile app with Web-based portalType 1 and type 2 diabetesManually entered; wirelessly transmitted from Accu-Chek Guide Me, Guide, and Aviva Connect; transferred from other Accu-Chek meters into the Accu-Chek Connect online portalShares reports with providers
    Go Dose system (approved but not on the market)NoYes (Humalog only)Mobile appType 2 diabetes——
    BlueStar RxPendingYesMobile-app with Web-based portalType 1 and type 2 diabetesManually entered; automatically transmitted from OneTouch Verio Flex, Accu-Check Aviva, Accu-Check Guide, TrueMatrix, Relion Premier Blu, Contour Next One, and Dexcom CGMShares reports with providers; stores personal health record; sends educational coaching messages; reminds user to take medication; communicates with providers
    d-Nav SystemYesYesMobile app with Web-based portalType 2 diabetesManually entered; BioTel and iGlucose meters automatically upload data to the phone app; pending new Cloud-based glucose meter and CGM will also transmit data automaticallyShares reports with providers
    GlucommanderYesYesWeb-basedType 1 and type 2 diabetesCellular-enabled glucose metersShares reports with providers
    DreaMedYesYesMobile app with Web-based portalType 1 diabetesAll meters, pumps, and CGM systems with regulatory approval can transmit via the Tidepool Diabetes Management SystemGives personalized diabetes management tips
    • ↵* Compatible systems include AgaMatrix Jazz Wireless 2, Ascensia Contour Next One, iHealthSmart, LifeScan OneTouch Verio Flex, LifeScan OneTouch Verio Sync, One Drop Chrome, Roche Accu-Chek Aviva Connect, and Roche Accu-Chek Guide. †A full list of compatible devices can be accessed at https://www.glooko.com/compatibility.

PreviousNext
Back to top
Clinical Diabetes: 38 (5)

In this Issue

December 2020, 38(5)
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by Author
  • Masthead (PDF)
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Clinical Diabetes.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Inpatient and Outpatient Technologies to Assist in the Management of Insulin Dosing
(Your Name) has forwarded a page to you from Clinical Diabetes
(Your Name) thought you would like to see this page from the Clinical Diabetes web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Inpatient and Outpatient Technologies to Assist in the Management of Insulin Dosing
Ling Cui, Pamela R. Schroeder, Paul A. Sack
Clinical Diabetes Dec 2020, 38 (5) 462-473; DOI: 10.2337/cd20-0054

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

Inpatient and Outpatient Technologies to Assist in the Management of Insulin Dosing
Ling Cui, Pamela R. Schroeder, Paul A. Sack
Clinical Diabetes Dec 2020, 38 (5) 462-473; DOI: 10.2337/cd20-0054
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Challenges of Inpatient Hyperglycemia Management
    • Inpatient Electronic Glucose Management Systems to Manage Insulin Doses
    • Challenges of Outpatient Hyperglycemia Management
    • Technologies to Assist in Outpatient Insulin Dosing
    • Conclusion
    • Article Information
    • Footnotes
    • References
  • Figures & Tables
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Improved Glycemic Control Following Transition to Tubeless Insulin Pump Therapy in Adults With Type 1 Diabetes
  • Practical Strategies to Help Reduce Added Sugars Consumption to Support Glycemic and Weight Management Goals
  • “Counting Carbs to Be in Charge”: A Comparison of an Internet-Based Education Module With In-Class Education in Adolescents With Type 1 Diabetes
Show more Feature Articles

Similar Articles

Navigate

  • Current Issue
  • Papers in Press
  • Abridged Standards of Care
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes
  • Diabetes Care
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Clinical Diabetes Print ISSN: 0891-8929, Online ISSN: 1945-4953.